This study aimed to evaluate the efficacy of high-resolution 3D contrastenhanced magnetic resonance angiography (3D CE MRA) with parallel imaging techniques for the diagnosis of various arterial stenoses and its value for planning endovascular interventional treatment. Thirty-five patients underwent 3D CE MRA before endovascular interventional treatment. Numbers of patients were as follows: clinically documented renal artery stenosis (n = 10), renal transplant artery stenosis (n = 1), carotid artery stenosis (n = 12), iliac artery stenosis (n = 11) and femoropopliteal artery stenosis (n = 1). A total of 39 arterial segments were treated. The depiction of various arterial stenoses was evaluated. The degree and length of the stenoses were compared and analyzed between 3D CE MRA and digital subtraction angiography (DSA). The accuracy of MRA in depicting lesion characteristics (ulceration, eccentricity, post-stenotic dilatation) was reviewed. The overall value of 3D CE MRA in planning interventional treatment was determined. The quality of 3D CE MRA in the demonstration of various arterial stenoses was judged excellent or good. A strong correlation was noted between 3D CE MRA and DSA regarding severity and length of stenosis. The accuracy of 3D CE MRA in depicting lesion characteristics was good. 3D CE MRA overestimated three severe iliac artery stenoses. Except in these three segments, the value of 3D CE MRA analysis was judged high. 3D CE MRA was found to be better than DSA in revealing the distal reconstitution and occluded segment in cases of iliac artery stenosis. 3D CE MRA is accurate in demonstrating the relevant anatomy necessary to plan endovascular interventional treatment for patients with arterial stenosis.
Introduction
Endovascular interventional treatment plays a vital role in the management of stenotic or occlusive vascular diseases caused by atherosclerosis. [1] [2] [3] [4] Pretreatment planning requires precise diagnosis of lesion location, severity and length. Traditionally, catheter-based X-ray angiography serves as the gold standard of these diseases. However, X-ray angiography is invasive and expensive. It involves ionizing radiation and the use of an iodinated contrast agent, which may increase the risk of renal failure in some patients. 5 It is also limited to one projection per injection and only those vessels con-taining a high enough concentration of iodinated contrast material will be seen. Recently, 3D contrast-enhanced magnetic resonance angiography (3D CE MRA) has emerged as a leading modality for the diagnosis of vascular diseases. [6] [7] [8] [9] It is noninvasive and requires only a peripheral venous injection of non-nephrotoxic gadolinium and involves no radiation. The limitations related to conventional non-contrast MRA such as time-of-flight (TOF) and phase-contrast (PC) MRA, which typically include flow artifacts, a long acquisition time, and mis-registration between slices due to multiple breath-holds, are also overcome. Apart from being primarily used for diagnostic purposes, 3D CE MRA may also serve as a modality for planning follow-up vascular interventions. However, earlier research was limited by poor spatial resolution and relatively slow imaging speed. Accordingly, the benefits of 3D CE MRA in planning vascular interventions have not been fully exploited. [10] [11] [12] The goals of this study were to evaluate highresolution 3D CE MRA with parallel imaging techniques in the detection of a variety of arterial occlusive diseases and to determine the potential benefits of this latest imaging technology for planning endovascular interventions.
Methods
Between 1 February 2006 and 29 March 2007, all patients who underwent 3D CE MRA for the assessment of arterial occlusive diseases in our department were followed prospectively. Those patients in whom 3D CE MRA led to conventional angiography with an intention for possible interventional treatment were included in this study. A total of 35 such patients were recruited. Their records and imaging studies were reviewed retrospectively. The patients included 27 men and eight women who ranged in age from 26 to 76 years (mean 54 years). All patients had clinically documented or suspected renal artery stenosis caused by atherosclerosis (n = 7) or fibromuscular dysplasia (n = 3), renal transplant artery stenosis (n = 1), carotid artery stenosis caused by atherosclerosis (n = 12), iliac artery stenosis caused by atherosclerosis (n = 11) and femoro-popliteal artery stenosis caused by atherosclerosis (n = 1). Informed consent was obtained from all patients.
All examinations were performed on a 1.5T MR scanner (Magnetom Avanto; Siemens AG, Erlangen, Germany) with a gradient strength of 45 mT/m and a slew rate of 200 mT/m per ms. Surface coils were used for signal reception. For 3D CE MRA, a coronal 3D fast-low-angle-shot (FLASH) sequence was used with the following parameters: TR = 2.8-3.5 ms, TE = 1.2 ms, flip angle = 15-25°, matrix size = 205 × 384-307 × 512, number of partitions = 72-88, partition thickness = 0.7-1.2 mm. The field of view (FOV) was centered over the region of interest and varied between 200 × 300 mm 2 and 390 × 390 mm 2 . The obtained spatial resolution was 1.0 × 0.8 × 0.7 mm 3 , 1.3 × 0.8 × 1.2 mm 3 , and 1.6 × 1.0 × 1.0 mm 3 for carotid artery, renal artery and lower extremity artery, respectively. Parallel acquisition with an acceleration factor of 2 was employed in all area of interest vessels. The acquisition time was 13-16 s. The renal arteries were scanned in breathhold and with fat suppression. For the carotid and lower extremity arteries, pre-contrast images were subtracted from the contrast-enhanced images. After a localizing scan, a pre-contrast scan was routinely obtained to ensure correct coverage of the region of interest. The post-contrast data acquisition was initiated by monitoring the targeted vessels with a rapid 2D fluoroscopic triggering turbo-Flash scan (CareBolus). The arrival of contrast agent in the targeted vessel prompted an operator to start the postcontrast acquisition. All patients received 0.2 mmol/ kg of gadopentate dimeglumine (Magnevist; Schering AG, Berlin, Germany). It was administered into an antecubital vein automatically with a power injector (MR Spectris; Medrad, Pittsburgh, PA, USA) at a rate of 2.0-3.0 ml/s, followed immediately by a 20-ml saline flush. The MR data sets were post-processed on a workstation (Leonardo, Siemens AG, Erlangen, Germany) and both maximum intensity projections (MIP) and multiplanar reconstructions (MPR) were rendered.
According to 3D CE MRA findings, a total of 40 abnormal arterial segments in 35 cases were identified, on which interventions were planned. They involved 10 segments of renal artery, one segment of renal transplant artery, 12 segments of carotid artery, 16 segments of iliac artery and one segment of femoro-popliteal artery. Percutaneous endovascular intervention was carried out within 12 days (mean 5.4 days) of 3D CE MRA. Immediately before intervention, all patients underwent digital subtraction angiography (DSA). The interventions attempted were balloon dilatation alone in four segments and stent placement with or without balloon dilatation in 35 segments. In one segment of iliac artery, no intervention was done because it was entirely occluded.
All images were evaluated in consensus by two experienced radiologists. First, the image quality of abnormal arteries shown on 3D CE MRA was scored on a 1-3 scale based on depiction of artery wall, blood signal homogeneity, artifact and vein contamination limiting the interpretation (1: poorinvisible or not adequately visible for diagnosis; 2: goodquite clear artery wall and moderate signal homogeneity, adequate for diagnosis; 3: excellentclear wall, homogenous signal and good contrast, excellent for diagnosis). Second, quantitative analysis of the degree (inner diameter of abnormal artery / inner diameter of adjacent normal artery × 100%) and length of stenosis was done on both 3D CE MRA and DSA. The existence of occlusion was separately noted. Lesion characteristics (eccentricity, ulceration, post-stenotic dilatation and tandem lesions) were analyzed on the two imaging modalities. DSA was considered the standard of reference for comparison with 3D CE MRA. Finally, the value of 3D CE MRA in planning the intervention was also scored on a 1-3 scale (1: lowprovided no or limited value in planning the intervention; 2: moderateprovided most but not all information for the intervention; 3: highprovided all needed information for planning the intervention). Besides the depiction of the lesion, the information needed for the intervention was defined as the pre-treatment choice of puncture site and operative approach, site and angle of catheter introduction in the target vessel, depiction of concomitant diseases on the route of the guide wire and catheter introduction, and choice of the stent length.
Pearson's correlation coefficient and the corresponding p-value between 3D CE MRA and DSA, regarding the degree and length of stenosis, were determined using SPSS 10.0 software (SPSS Inc. Chicago, IL, USA). The accuracy of 3D CE MRA in depicting the lesion characteristics was also reviewed.
Results (Figures 1-8)
Of all 40 artery segments in 35 patients, the mean score of image quality was 2.9. Thirty-seven segments were graded 3. The remaining three segments, which were renal arteries, were graded 2 because of vein contamination. But the demonstration of these three segments was still adequate for diagnosis on MPR images.
The severity of stenosis measured by DSA and 3D CE MRA was 79.6 ± 16.2% and 81.3 ± 15.6%, respectively. The length of stenosis measured on DSA and 3D CE MRA was 1.4 ± 0.5 cm and 1.4 ± 0.5 cm. Strong correlation was found between these two imaging methods with respect to severity and length of stenosis (r = 0.98; p < 0.01).
Nine artery segments were diagnosed as occluded on 3D CE MRA. Six of them were confirmed on DSA. The other three segments, which were iliac arteries, were found severely narrowed on DSA.
In 31 stenotic segments (nine occluded segments were excluded), DSA depicted that 12 were eccentric. Eleven of these 12 segments were showed by 3D CE MRA. The accuracy of 3D CE MRA in demonstration of eccentricity was 96.8% (30/31). Ulceration was found on DSA in five of 31 stenotic segments. Four of these five segments were found For the value of 3D CE MRA in planning intervention, the mean score was 2.8. Thirty-four segments were scored 3 (85%), three segments scored 2 (7.5%), and the remaining three segments scored 1 because of misdiagnosis of significant stenoses as occlusion. In one of seven patients with renal artery stenosis, MRA showed an abdominal aorta aneurysm simultaneously, which was clinically unsuspected. In four of these seven cases, 3D CE MRA found concomitant wall irregularity and stenosis in aorto-iliac arteries. In 11 cases with iliac artery stenosis, MRA found that the abnormality was bilateral in five cases. In three cases with iliac artery occlusion, DSA did not show the distal reconstitution of the occlusion. On the contrary, 3D CE MRA clearly showed the distal reconstituting artery and the occlusion length.
DSA was performed successfully in all 35 cases. Intervention was done on 39 of 40 diseased segments with one occluded iliac artery left untreated because it was completely occluded and the occlusion was too long.
Discussion
Because it is less invasive and has better reproducibility compared to surgical revascularization, percutaneous endovascular intervention is increasingly applied to treat stenotic and occlusive arterial diseases. [1] [2] [3] [4] The information about lesion extent, length and concomitant diseases, which may influence treatment procedure and outcome, is required before intervention. Many non-invasive imaging techniques, including ultrasonography (US), CT angiography (CTA), and conventional nonenhanced MRA, can be used in clinical practice.
But all these modalities have their weaknesses. US has a limited FOV and is operator-dependent. CTA involves ionizing radiation and a large dose of iodinated contrast agent. The postprocessing of CTA is time-consuming. Furthermore, the precise grading of the stenosis by CTA may be affected by calcification on the vessel wall. 13 Conventional non-contrast MRA, including TOF and PC MRA, is based on native flow effects. It suffers from flow artifact, significant overestimation of stenosis, and a long acquisition time. 3D CE MRA overcomes most of these limitations and becomes increasingly popular in patients and physicians. Contrast agents used by 3D CE MRA, such as gadopentetate dimeglumine, decrease the T1 relaxation time of blood and substantially increase intravascular signal. This contrast material enhancement provides vascular contrast considerably higher than that obtained with native flow in conventional non-contrast MRA techniques. Consequently, imaging speed and lesion delineation is significantly improved.
This study was to evaluate the latest 3D CE MRA technique before endovascular interventional treatment in a variety of stenotic artery diseases. There were two technical improvements in our study. One was a real-time fluoroscopic triggering scan, which was employed to monitor the appearance of the contrast media in target vessels and to synchronize the scan time. By doing so, precise timing of 3D CE MRA was achieved to ensure optimal arterial enhancement. Another technique was parallel acquisition with an acceleration factor of 2. It was based on a recently developed multi-coil and multi-channel MR system. The parallel imaging technique uses spatial information contained in the component elements of a coil array to partially replace spatial encoding, which would normally be performed by using gradients, thereby reducing imaging time and/or increasing spatial resolution. 14, 15 The resolution obtained in our study was higher than that in the literature. [10] [11] [12] It was 1.0 × 0.8 × 0.7 mm 3 , 1.3 × 0.8 × 1.2 mm 3 , and 1.6 × 1.0 × 1.0 mm 3 for carotid artery, renal artery and lower extremity artery, respectively. And the acquisition time was shortened, which was beneficial for reducing the vein contamination and the patient's breath-holding. As a result, our new technique offered improved diagnostic image quality, compared to previous studies. [10] [11] [12] We found that the diagnostic value of 3D CE MRA was comparable to DSA. The correlation between 3D CE MRA and DSA in the depiction of the severity and length of the stenosis was strong. The accuracy of 3D CE MRA in the demonstration of lesion characteristics was good. Furthermore, using this high-resolution technique, even the subtle 'string-of-beads' appearance of renal artery fibromuscular dysplasia was well appreciated in three patients (see Figures 4 and 5) . However, there was misdiagnosis of 3D CE MRA in distinction between severe stenosis and occlusion. In this study, three iliac arteries with significant stenosis were overestimated by 3D CE MRA as occlusion. Earlier studies 16, 17 had reported the similar findings that 3D CE MRA was prone to overestimation of the stenosis. This overestimation could be caused by intravoxel dephasing, low spatial resolution, possible susceptibility and motion artifacts, which were less severe with 3D CE MRA compared with non-contrast MRA. Although the spatial resolution was improved using parallel acquisition techniques, the signal-to-noise ratio of the small vessels was lowered, and the severely narrowed vessels were under-filled with arterial contrast injected from a peripheral vein and difficult to distinguish from an occlusion. But for DSA, a large volume of contrast material was infused directly into the lumen proximal to the lesion at a much higher rate. In addition, DSA has an intrinsically higher spatial resolution than 3D CE MRA, especially for vessels with a small caliber. As a result, DSA was better to demonstrate severely narrowed arterial lesions than 3D CE MRA, which could influence interventional treatment options.
It should be noted that, in three cases in which DSA failed to show distal reconstitution of complete segmental iliac occlusions, such information could be well demonstrated on 3D CE MRA. We believe that 3D CE MRA offers an advantage in this respect compared to DSA. Rather than using a direct intra-arterial bolus of contrast material at the distal abdominal aorta, as DSA does, 3D CE MRA instead relies on an intravenous bolus and a vascular enhancement during the first pass of the contrast material. Unlike with DSA, the entire cardiac stroke volume is opacified. Because of this, 3D CE MRA is more likely than DSA to opacify all collateral pathways and, therefore, is more accurate in demonstrating patent runoff vessels distal to segmental occlusions. This may be also related to better soft tissue contrast, an inherent advantage of MRI than that of X-ray technology. By using more iodinated contrast material and delayed photography, or using vasodilators simultaneously, the demonstration of distal reconstitution with DSA may be possible. But the risk of iodine-related nephrotoxicity and the complexity of the manipulation are increased.
In this study, 3D CE MRA was found to be helpful in planning interventions. With a large FOV and multi-planar capability, 3D CE MRA offered a great deal of important pre-procedural anatomic information that could directly impact the interventional procedure in the following aspects: (1) selecting the optimal puncture site and vascular access approach with the lowest risk and highest success rate for the planned intervention; (2) identifying the level, angulation, and orientation of the target artery for catheterization; (3) depicting lesion characteristics in the case of a sub-occlusive eccentric lesion, which can be valuable to safely navigate difficult lesions and even recanalize total occlusions; and (4) demonstrating significant concomitant vascular conditions such as aortoiliac occlusive disease and aneurysmal disease with mural thrombus when evaluating renal artery stenosis. Sharafuddin et al. 11 reported that pre-interventional 3D CE MRA significantly reduced the iodinated contrast agent load and procedure time during percutaneous renal artery interventions. According to our experience and that of others, 10, 11 we believe pre-interventional 3D CE MRA can facilitate the use of less iodinated contrast material required during interventions, especially in patients with renal insufficiency, by providing an assessment of the global vascular anatomy prior to the interventional procedure. Although X-ray angiography remains necessary to confirm the MRA findings and fully characterize lesion morphology before intervention, it can be restricted now that only selective injections into the intervention territory are required. Currently, 3D CE MRA is frequently performed in our institution before interventional treatment. Through our picture archiving and communication system, both source and postprocessing images of 3D CE MRA can be sent to the workstation in the interventional suite and used as a possible roadmap for the interventional procedure.
The limitations of this study include the relatively small number of patients and the subjective assessment of image quality and value of 3D CE MRA for planning intervention. Furthermore, 3D CE MRA is more expensive than other non-invasive screening modalities and does add cost to intervention. As a result, the cost-benefit ratio for 3D CE MRA in the various pre-interventional applications has yet to be evaluated in future prospective studies. Although the technique of 3D CE MRA continues to be refined with further developments in imaging hardware and software, one must be aware of the inherent limitation of MRA in the identification of arterial calcification, a feature pertinent to the management of certain arterial lesions.
In conclusion, our preliminary study shows that high-resolution 3D CE MRA is accurate in demonstrating the relevant anatomy necessary to plan endovascular interventional treatment for patients with arterial occlusive disease.
